BRISTOL MYERS SQUIBB
- Country
- ๐ซ๐ทFrance
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2007-10-02
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002067
- Locations
- ๐บ๐ธ
Dr Mark Goldstein, Los Angeles, California, United States
๐บ๐ธEisenhower Med Ctr, Rancho Mirage, California, United States
๐บ๐ธNorthwestern Univ Med School, Chicago, Illinois, United States
A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-08-05
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002308
- Locations
- ๐บ๐ธ
Bristol - Myers Squibb Co, Princeton, New Jersey, United States
A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-08-05
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002280
- Locations
- ๐บ๐ธ
Bristol - Myers Squibb Co, Wallingford, Connecticut, United States
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-08-05
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002307
- Locations
- ๐บ๐ธ
SUNY / Health Sciences Ctr at Stony Brook, Stony Brook, New York, United States
๐บ๐ธEast Bay AIDS Ctr, Berkeley, California, United States
๐บ๐ธChildren's Hosp of Los Angeles, Los Angeles, California, United States
A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-04-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 40
- Registration Number
- NCT00002349
- Locations
- ๐บ๐ธ
Naval Med Ctr, Portsmouth, Virginia, United States
๐บ๐ธNorthwest Med Ctr, Seattle, Washington, United States
๐บ๐ธSan Diego Naval Hosp, San Diego, California, United States
Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002240
- Locations
- ๐บ๐ธ
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
๐บ๐ธAlbany Med College, Albany, New York, United States
๐บ๐ธClinsites / Sorra Research Ctr, Birmingham, Alabama, United States
A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 20
- Registration Number
- NCT00002246
- Locations
- ๐บ๐ธ
AIDS ReSEARCH Alliance, West Hollywood, California, United States
๐บ๐ธMount Sinai Hosp, New York, New York, United States
๐ฌ๐งCharing Cross and Westminster Med School, London SW 10, United Kingdom
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-05-04
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 730
- Registration Number
- NCT00005918
- Locations
- ๐บ๐ธ
The CORE Ctr, Chicago, Illinois, United States
๐บ๐ธUniv of Texas Med Branch, Galveston, Texas, United States
Tan tock Seng Hosp
Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-04-25
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 120
- Registration Number
- NCT00002224
- Locations
- ๐บ๐ธ
Chicago Ctr for Clinical Research, Chicago, Illinois, United States
๐บ๐ธUniv of Kansas School of Medicine, Wichita, Kansas, United States
๐บ๐ธBeacon Clinic / Boulder Community Hosp, Boulder, Colorado, United States
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-04-25
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00002411
- Locations
- ๐บ๐ธ
Northwestern Univ / Div of Infect Diseases, Chicago, Illinois, United States
๐บ๐ธRush Presbyterian / ST Lukes Med Ctr, Chicago, Illinois, United States
๐บ๐ธUniv of Texas / Med Branch at Galveston, Galveston, Texas, United States